Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/51541
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Aspirin for primary prevention: do potential benefits outweigh the risks? |
Author: | Shakib, S. |
Citation: | Internal Medicine Journal, 2009; 39(6):401-407 |
Publisher: | Blackwell Publishing Asia |
Issue Date: | 2009 |
ISSN: | 1444-0903 1445-5994 |
Statement of Responsibility: | S. Shakib |
Abstract: | The role of aspirin for primary prevention in healthy individuals has been the subject of clinical trials for more than a quarter of a century. Because of this evidence, or sometimes despite it, many individuals self-administer aspirin to prevent cardiovascular events. This article reviews the published work for aspirin in primary prevention of cardiovascular and malignant diseases and considers whether aspirin would be approved by regulatory authorities for this use if it were to be marketed for this indication today. |
Keywords: | Animals Humans Neoplasms Cardiovascular Diseases Gastrointestinal Hemorrhage Aspirin Risk Assessment Risk Factors Primary Prevention |
Rights: | © 2009 The Authors |
DOI: | 10.1111/j.1445-5994.2008.01888.x |
Published version: | http://dx.doi.org/10.1111/j.1445-5994.2008.01888.x |
Appears in Collections: | Aurora harvest Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.